Published in Hepatitis Weekly, July 5th, 2004
The Foundation recognizes Pestka, chairman and chief scientific officer of PBL Biomedical Laboratories, for his seminal accomplishments in purifying, characterizing and cloning human interferon-alpha, or Hu-IFN-alpha, a virus-fighting substance produced by white blood cells.
David V. Goeddel, PhD, and Charles Weissmann, MD, PhD, share the prize for crucial work in which they cloned Hu-IFN-alpha in the bacterium E. coli and demonstrated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.